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Abstract Neurotransmission and synaptic strength depend
on expression of post-synaptic receptors on the cell surface.
Post-translational modification of receptors, trafficking to the
synapse through the secretory pathway, and subsequent inser-
tion into the synapse involves interaction of the receptor with
A-kinase anchor proteins (AKAPs) and scaffolding proteins.
Neurobeachin (Nbea), a brain specific AKAP, is required for
synaptic surface expression of both glutamate and GABA
receptors. Here, we investigated the role of Nbea-dependent
targeting of postsynaptic receptors by studying Nbea interac-
tion with synapse-associated protein 102 (SAP102/Dlg3) and
protein kinase A subunit II (PKA II). A Nbea mutant lacking
the PKA binding domain showed a similar distribution as
wild-type Nbea in Nbea null neurons and partially restored
GABA receptor surface expression. To understand the rele-
vance of Nbea interaction with SAP102, we analysed SAP102
null mutant mice. Nbea levels were reduced by ~80 % in
SAP102 null mice, but glutamatergic receptor expression
was normal. A single-point mutation in the pleckstrin homol-
ogy domain of Nbea (E2218R) resulted in loss of binding with
SAP102. When expressed in Nbea null neurons, this mutant
fully restored GABA receptor surface expression, but not glu-
tamate receptor expression. Our results suggest that the PKA-
binding domain is not essential for Nbea’s role in receptor
targeting and that Nbea targets glutamate and GABA recep-
tors to the synapse via distinct molecular pathways by
interacting with specific effector proteins.
Keywords Synapse . Neurobeachin . AKAP . SAP102 .
Glutamate receptors . GABA receptors
Introduction
The number of functional neurotransmitter receptors in the
postsynaptic membrane is the dominant factor in the regula-
tion of synaptic strength. Receptor abundance and mobility in
the postsynaptic membrane are regulated by different mecha-
nisms, such as constitutive and activity dependent insertion,
local mobility such as recycling via endo/exocytosis and lat-
eral diffusion from extra-synaptic sites [1–3]. Membrane-
associated guanylate kinases (MAGUKs) in the discs large
family (Dlg) of scaffolding proteins are central in the regula-
tion of receptor abundance and mobility in excitatory neurons
[4]. Mutations of Dlg proteins in mice and humans result in
cognitive disorders and impairments in synaptic plasticity
[5–7]. These scaffold proteins link NMDA and AMPA recep-
tors with signalling and structural proteins in postsynaptic
multiprotein complexes. Evidence suggests that MAGUKs
Electronic supplementary material The online version of this article
(doi:10.1007/s12035-015-9164-8) contains supplementary material,
which is available to authorized users.
* M. Verhage
m.verhage@vu.nl
1 Department of Functional Genomics, Centre for Neurogenomics and
Cognitive Research (CNCR), Neuroscience Campus Amsterdam,
VU Medical Centre, VU University Amsterdam,
1081HVAmsterdam, The Netherlands
2 Department of Molecular and Cellular Neurobiology, Centre for
Neurogenomics and Cognitive Research, Neuroscience Campus
Amsterdam, VU University Amsterdam,
1081HVAmsterdam, The Netherlands
3 Centre for Clinical Brain Sciences, Edinburgh University,
Edinburgh EH16 4SB, United Kingdom
4 Department of Clinical Genetics, Centre for Neurogenomics and
Cognitive Research, Neuroscience Campus Amsterdam, VU
Medical Centre, VU University Amsterdam,
Amsterdam, The Netherlands
Mol Neurobiol (2016) 53:2112–2123
DOI 10.1007/s12035-015-9164-8
assemble with the receptor subunits during biosynthesis in the
Golgi and when this interaction is disturbed, NMDAs do not
reach the synapse [8–10]. However, the principles of receptor
assembly and targeting to the synapse are largely unknown.
Another class of scaffold proteins playing an important role
in excitatory synapses are A-kinase anchoring proteins
(AKAP), which bind the regulatory subunit of protein kinase
A (PKA). In mice lacking the AKAP protein neurobeachin
(Nbea), synaptic transmission is severely impaired [11], and
they die shortly after birth [12]. Loss of Nbea results in re-
duced spine number in cultured neurons [13] and modifica-
tions in the composition of synaptic proteins [14]. Nbea binds
to the MAGUK protein synapse-associated protein 102
(SAP102/Dlg3) [15] and the type II regulatory subunit of pro-
tein kinase A (PKA II) [16]. Thus, Nbea may be involved in
recruiting and targeting PKA to specific substrate proteins.
Synaptic surface expression of both inhibitory (GABAergic)
and excitatory receptors (NMDA, AMPA and kainate) are
decreased by Nbea loss, suggesting that Nbea controls a ge-
neric principle of receptor targeting, despite the fact that the
mechanisms of receptor targeting appear to be different for
GABAergic and glutamatergic receptors [17].
The aim of this study was to dissect different pathways that
Nbea coordinates to target neurotransmitter receptors to the
synapse. We used primary neurons from Nbea null mutant
mice and rescued these neurons using a Nbea mutant that lost
affinity for the glutamate receptor interacting protein SAP102.
This Nbea mutant is vital for glutamate receptor signalling but
not required to support GABA receptor signalling. The Nbea
mutant designed to block the previously characterised interac-
tion with PKA II modulates GABAergic and glutamatergic
signalling. We conclude that Nbea uses distinct pathways to
target glutamate and GABA receptors to the synaptic surface.
Understanding these mechanisms may be relevant to the roles
of Nbea and SAP102 in humans carrying mutations in these
genes that result in idiopathic autism [18] and intellectual dis-
ability, respectively [19].
Methods
Laboratory Animals, Primary Hippocampal Cultures
and Cell Lines
Nbea and SAP102 null mutant mice have been described pre-
viously [5,12]. Embryonic day 18 (E18) embryos were obtain-
ed by caesarean section of pregnant females through timed
heterozygous mating. Hippocampi were dissected from E18
Nbea and SAP102 pups. After removal of meninges, hippo-
campi were collected in ice-cold Hank’s balanced salt solution
(HBSS; Sigma), buffered with 7-mMHEPES (Invitrogen) and
further dissociated before plating on glia feeder layer as de-
scribed previously [15]. For electrophysiology, 25,000
neurons and for immune-cytochemistry, 2000 neurons per
18-mm cover slip were used. For whole-brain lysate, E18
and P84 mice were decapitated; whole brains and different
parts of brains were removed and immediately frozen. For
immunoblots, brains were boiled in 1XLaemmli Sample buff-
er. For immunoprecipitation experiments in heterologous
cells, human embryonic kidney cells 293T (HEK293T) were
used.
Generation of Nbea Mutant Constructs
Full-length Nbea construct has been described previously
[15]. A Nbea construct deficient for binding PKA II was gen-
erated by cloning Nbea in two parts: 1-1081aa and 1099-
2936aa separately and by joining via restriction sites thereby
deleting the 27 amino acid (aa) hypothesised PKA binding site
(1081-1099aa) to create PKA mut Nbea (NbeaΔPKA). The
SAP102 binding-deficient E2218R mutation was initially cre-
ated in the C-terminus of Nbea using QuickChangeTM Site-
DirectedMutagenesis Kit [15]. The C-terminus containing the
mutation was re-cloned into full-length Nbea. Phospho-fructo
kinase muscle (PFKM) is a putative interactor of Nbea that
was identified in mass spectrometry analysis performed as
reported previously [15]. Entry clone of human PFKM
(Entrez Gene ID: 5213) was a gift from Erich E. Wanker
(Max Delbrück Center for Molecular Medicine, Berlin,
Germany).
HEK Cell Transfection, Co-Immunoprecipitation,
Immunofluorescence Staining
HEK cell transfection and immunoprecipitation to determine
Nbea wild-type (WT) and E2218R binding with SAP102 and
PFKM was performed as detailed previously [15]. SAP102
and Nbea WT and KO neurons were allowed to grow till
day in vitro (DIV) 14 before fixation. Nbea KO neurons
transfected with NbeaΔPKA and E2218R Nbea at DIV 3
were fixed between DIVs 15 and 17. α-SAP102 (mouse
monoclonal, NeuroMab clone N19/2, 1:100), α-Nbea (rabbit
polyclonal, SySy, 1:1000), α-MAP2 (chicken polyclonal,
Abcam ab5392, 1:10000) and α-Actin (mouse monoclonal,
Chemicon, 1:200) were used for immunofluorescence stain-
ing. Detailed description of staining procedure and Nbea an-
tibody description has been reported previously [15].
Neuron Transfection and Electrophysiology
Nbea null mutant neurons (25 k/18-mm coverslip) were
transfected with WT Nbea, E2218R Nbea or NbeaΔPKA to-
gether with enhanced green fluorescent protein (EGFP) as
morphology marker at 3 days in vitro (DIV 3) as described
previously [20]. Whole-cell voltage clamp recordings were
performed at DIVs 14–18 for GABA and glutamate-induced
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response. Cells were kept in a voltage clamp (membrane po-
tential, Vm=−70 mV) using Axopatch 200B amplifier (Axon
Instruments) with borosilicate glass pipettes (2–4 mOhm)
containing 125 mM K+-gluconic acid, 10 mM NaCl, 4.6
MgCl2, 4 mM K2-ATP, 15 mM creatine phosphate
(Calbiochem), 1 mM EGTA and 20 U/ml phosphocreatine
kinase (pH 7.3, 300 mOsm). All chemicals were from Sigma
Aldrich unless otherwise stated. Series resistance was always
70 % compensated and cells with holding current lower than
−300 pA were discarded. The external solution contained
140 mM NaCl, 2.4 mM KCl, 4 mM CaCl2, 4 mM MgCl2,
10 mM HEPES, and 10 mM glucose (pH 7.3, 300 mOsm).
Then, 300 nM TTX (Abcam) were added to external medium
before recording; 30 μM glutamate or 3 μM GABA was
applied by a 20-ms pressure ejection from a glass elec-
trode (~2.8 mOhm). Digidata 1440A and pCLAMP 10
software (Axon instruments) were used to record all
signals. All experiments were performed at ambient
temperature (20–23 °C).
RNA Isolation, Real-Time qPCR and Pharmacological
Treatment of Cultured Neurons
For RNA isolation, hippocampus of SAP102 WT and KO
mice were homogenised in TRIzol reagent and total RNA
was isolated using the QIAcube (QIAGEN, Venlo,
The Netherlands). The protocol was used according to the
manufacturer’s specifications. RNA concentrations and purity
were assessed by OD measurements at 260 and 280 nm on a
NanoDrop spectrophotometer (Thermo Scientific). For com-
plementary DNA (cDNA) synthesis, 1 μg of RNA and
125 pmol OligoT12 primer dissolved in a total of 10-μl H20
and incubated at 72 °C for 10 min. Reverse transcriptase mix
was added, consisting of 5-μl 5X first-strand buffer
(Invitrogen), 0.5 μl SuperScript II RNA polymerase
(Invitrogen), 10 mM dNTPs, and 25 mM MgCl2 in a total
of 15-μl H2O. The mixture was incubated at 42 °C for 1 h,
followed by 15 min at 70 °C. cDNA quality was assessed on
0.8 % agarose gel. Real-time quantitative PCR (qPCR) was
performed using the Light Cycler 480 system (Roche Applied
Science, Indianapolis, IN, USA) on SAP102 WT and KO
hippocampus. Oligonucleotide primers (Sigma) used for Nbea
qPCR were FW: tggctcaaatggagatcaatg and RW:
tgtacagctgcttaaagtcacagg. Reaction volumes of 5 μl contained
cDNA, 0.1 μM of Universal Probe Library probe 22 (Roche
Applied Sciences), 0.4 μM forward primer, 0.4 μM of reverse
primer and 2.5 μl 2X LightCycler 480 Probes Master (Roche
Applied Science). After initial denaturation for 10 min at
95 °C, amplification was performed using 35 cycles of dena-
turation (95 °C for 10 s), followed by annealing (58 °C for
15 s) and elongation (72 °C for 15 s). Results were analysed
using the LightCycler 480 software (Roche Applied Science)
version 1.5. Eukaryotic elongation factor 1-alpha 1 (Eef1a1) is
the reference gene to which Nbea messenger RNA (mRNA)
levels were normalised to within samples. 0.1 μM of Univer-
sal Probe Library probe 31 (Roche Applied Sciences) was
used for Eef1a1 gene.
Cycloheximide (CHX) treatments were performed by
adding CHX (100 ug/ml Sigma) to cultured mouse cortical
neurons at DIV 10 from SAP102 null mice in combination
with MG132 (10 μM; Santa Cruz), Leupeptin (25 μM; Sig-
ma). After 24 h, neurons were dissolved directly in 2X SDS
sample buffer.
Image Analysis and Quantification
The GelAnalyzer tool in ImageJ was used to quantify Nbea
and SAP102 protein levels in brain lysate. Levels were nor-
malised to valosin-containing protein (VCP) or actin, respec-
tively. Images of neuronal cultures were captured on a Zeiss
LSM 510 confocal microscope using a ×40 oil objective (N.A.
1.3) and ×0.7 mechanical zoom and appropriate filter settings.
Acquired images were analysed in a semi-automated fashion
using MATLAB-based software, SynD [21]. Nbea null neu-
rons expressingWTNbea, E2218RNbea or NbeaΔPKAwere
identified by EGFP. Confocal settings were kept the same for
all scans between groups.
Statistical Tests
Statistical analysis was performed using SPSS (IBM SPSS
Statistics 21). The Student’s t test was performed taking into
account Levene’s test for equality of variances. Kolmogorov-
Smirnov and Shapiro-Wilk tests were used to test for normal-
ity of data distribution. A Mann-Whitney test for two inde-
pendent samples was applied when groups were not normally
distributed. This study contains nested data, thus when the
intra cluster correlation was high (>0.10), which was the case
in all electrophysiological data, multilevel modelling was per-
formed to decrease false positives as has been described [22].
The multilevel model was used to find significant difference
between three groups (Nbea KO, Nbea KO +WTNbea, Nbea
KO +mutated Nbea) where experimental week was chosen as
cluster in which the measurements were nested. When the
number of weeks and number of measurements per week
allowed, both the intercept and slope where modelled as ran-
dom coefficients. However, if there was not enough data to fit
this complex model, only the intercept was included as a ran-
dom coefficient when predicting significant differences be-
tween groups. Data is represented as mean±standard error of
the mean (SEM). Each condition of each data set has the
number of neurons measured over the number of inde-
pendent experiments/cultures through which the mea-
surements were taken.
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Results
PKA Binding-Deficient Nbea Rescues Glutamate
and GABA Receptor Signalling in Nbea Null Neurons
To test the importance of the Nbea interaction with PKA II in
targeting of glutamate and GABA receptors, we generated
PKA binding-deficient Nbea (NbeaΔPKA) by deletion of
amino acids 1081–1099aa in full-length Nbea as outlined be-
fore [23] (Fig. 1a). Nbea null mutant (Nbea KO) neurons
expressing NbeaΔPKA or wild type Nbea (WT Nbea)
showed a similar punctate localization pattern of Nbea in den-
drites and the cytoplasm as observed previously for endoge-
nous Nbea [11] (Fig. 1b). Dendritic length, and the number of
Nbea puncta in dendrites did not differ between the two
groups (Fig. 1c, d). NbeaΔPKA expressionwas higher in both
soma and dendrites compared toWT Nbea (Fig. 1e, f), but the
subcellular distribution of Nbea puncta and synapses was sim-
ilar in both the conditions (Fig. 1g, h). We analysed postsyn-
aptic receptor signalling by application of 30-μMglutamate or
3-μM GABA on Nbea KO neurons expressing WT Nbea or
NbeaΔPKA. In line with our previous results [11], expression
of WT Nbea increased the amplitude of spontaneous inputs
(miniature post synaptic currents, mPSC). This was not ob-
served in neurons expressing NbeaΔPKA (Fig. 1j). mPSC
frequency appeared higher in null neurons expressing WT
Nbea or NbeaΔPKA but due to the frequency variability this
did not reach statistical significance (Fig. 1k). Nbea KO neu-
rons have a strongly reduced response to application of
30-μM glutamate or 3-μM GABA, which can be restored to
wild-type levels by re-introduction of WT Nbea [11] (Fig. 1l–
n). Compared to Nbea KO neurons rescued with WT Nbea,
NbeaΔPKA expressing neurons showed a similar response to
glutamate application (Fig. 1l, m). However, the GABA-
induced response, although higher than in Nbea KO neurons,
was significantly lower in NbeaΔPKA expressing neurons
compared to neurons expressing WT Nbea (Fig. 1l, n). Our
data shows that PKAII interaction is not required for Nbea
function, although rescue appears to be incomplete when ex-
pressing the NbeaΔPKA on the null background.
Nbea Levels are Reduced in SAP102 KO Mice
SAP102/Dlg3 has been identified as an interactor of Nbea in
immunoprecipitation experiments from brain homogenates of
embryonic (E18) and adult (P84) mice [15]. To understand the
relevance of this interaction, we analysed Nbea levels in
SAP102 null mutant mice (SAP102 KO). Nbea levels in E18
and P84 brain lysates of SAP102 KO mice were significantly
reduced (Fig. 2a, Suppl Fig. 1a, b). Quantitative PCR (qPCR)
analysis revealed no difference in mRNA levels of Nbea in
SAP102 KO neurons compared to SAP102 WT (Suppl
Fig. 2a). To further investigate how Nbea is degraded in
SAP102 null mice, we treated SAP102 KO neurons with the
protein translation blocker cycloheximide (CHX), proteasome
blocker MG132 or lysosome blocker leupeptin. Compared to
CHX only, we observed a significant increase in Nbea levels
after 24 h of CHX + MG132 but not with the lysosomal
blocker leupeptin indicating that Nbea is degraded via
ubiquitin-proteasome system (Suppl Fig. 2b, c).
Morphological analysis of cultured SAP102 KO neurons at
DIV 14 showed a strong reduction in the number of Nbea
puncta in dendrites and intensity of expression in the soma
of SAP102 KO neurons (Fig. 2b, c, g). The dendritic length of
SAP102 KO neurons was also significantly reduced (Fig. 2d),
as well as the number of Nbea puncta per μm dendrite
(Fig. 2e). Although Nbea expression is strongly reduced in
Fig. 1 Expression of NbeaΔPKA in Nbea null neurons partially rescues
GABA receptor surface expression. a Schematic drawing of mouse Nbea
showing 22 amino acid deletions to generate NbeaΔPKA. The N-
terminus consist concavanalin A (Con A)-like lectin domain surrounded
with predicted armadillo (ARM) repeats. The C-terminus has the domain
of unknown function 1088 (Duf; in blue), the Pleckstrin homology-like
domain (PH; in red), the Beach domain (brown) and the WD40 repeats
(yellow). Small pink box depicts 1081–1099aa deleted fromNbeaΔPKA.
b Representative image of Nbea KO neurons expressing WT Nbea and
NbeaΔPKA depicts similar distribution in cultured neurons. c Total
number of Nbea puncta in a Nbea KO neuron expressed with WT Nbea
and NbeaΔPKA are similar (n=49, 5 independent experiments; ns not
significant). d Dendritic length of Nbea KO neurons rescued with
NbeaΔPKA and WT Nbea is not different. e Fluorescent intensity of
NbeaΔPKA is significantly higher than that of WT Nbea in dendrites
(WT Nbea=666.1±26.52 a.u., n=49, NbeaΔPKA=1269±65.31, n=45;
Mann-Whitney Test, ***p<0.001). f Somatic intensity of NbeaΔPKA is
also higher than that of WT Nbea (WT Nbea=789.5±112 a.u., n=19,
NbeaΔPKA=1182±190.8 a.u., n=19; ns). g Sholl analysis shows that
NbeaΔPKA distribution is similar compared to WT Nbea. h Sholl
analysis of synapses in neurons expressing NbeaΔPKA is similar to
WT Nbea. i Representative trace of spontaneous minis of Nbea KO
neurons, Nbea KO rescued with WT Nbea, and Nbea KO rescued with
NbeaΔPKA. j Amplitude of spontaneous minis of Nbea KO neurons
rescued with NbeaΔPKA is insignificant compared to Nbea KO
neurons alone (Nbea KO=20.84±1.302, n=25, Nbea KO + WT Nbea:
26.72±2.074, n=25, Nbea KO + NbeaΔPKA=21.90±1.635, n=21, 5
independent experiments). k Frequency of spontaneous minis of Nbea
KO neurons, Nbea KO rescued with NbeaΔPKA, or with WT Nbea are
insignificant between groups (Nbea KO=2.808±0.4671, n=25, Nbea
KO + WT Nbea=4.921±0.9449, n=25, Nbea KO + NbeaΔPKA=
5.268±1.353, n=21, 5 independent experiments). l Representative
traces of exogenously applied glutamate (30 μM) and GABA (3 μM)
on Nbea KO neurons (green), Nbea KO rescued with WT Nbea (red)
and Nbea KO rescued with NbeaΔPKA (blue). m Expression of WT
Nbea and NbeaΔPKA in Nbea KO has significantly higher glutamate-
induced responses than Nbea KO neurons. Responses of WT Nbea and
NbeaΔPKA neurons are not significantly different (Nbea KO=231.98±
36.99, n=30, Nbea KO + WT Nbea=833.64±99.42, n=22, Nbea KO +
NbeaΔPKA=638.1±59.82, n=23, 5 independent experiments). n
GABA induced responses are partially rescued by re-expression of
NbeaΔPKA in Nbea null neurons (Nbea KO=172.75±40.80, n=19,
Nbea KO + WT Nbea = 529.56 ± 40.42, n = 18, Nbea KO +
NbeaΔPKA=314.96±43.91, n=18, 3 independent experiments). A
two-level multilevel statistical analysis was performed including
random intercepts. **p<0.01, ***p<0.001. All data are mean±SEM
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SAP102 KO neurons, it is still distributed throughout the den-
drite (Fig. 2f). In contrast to these SAP102-dependent Nbea
phenotypes, in Nbea KO mice, SAP102 levels were un-
changed in whole-brain lysates (Fig. 2h), and total numbers
of SAP102 puncta, dendritic length and distribution of
SAP102 puncta were the same as in WT neurons (Fig. 2j–
m). These observations suggest that SAP102 plays an essen-
tial role in Nbea expression whereas SAP102 expression is
independent of Nbea.
Glutamate Receptor Signalling Is Unchanged in SAP102
Null Neurons
To test whether glutamate receptor signalling is impaired in
SAP102 null neurons due to the lower Nbea levels, we record-
ed spontaneous miniature excitatory postsynaptic currents
(mPSCs) in SAP102 WT and KO neurons. Amplitude and
frequency were unchanged in SAP102 KO compared to WT
(Fig. 3a, b). In addition, exogenous application of 30-μM
glutamate showed no significant difference between SAP102
WT and KO neurons (Fig. 3c, d). Hence, despite the ±80 %
reduced levels of Nbea in SAP102 null mice, glutamate sig-
nalling is unchanged.
E2218R Nbea Restores Inhibitory Transmission in Nbea
Null Neurons
Previously, we have shown that Nbea binds SAP102 via its C-
terminus and that a point mutation (E2218R) in the pleckstrin
homology (PH) domain of Nbea results in loss of this binding
[15]. We engineered this point mutation in full-length Nbea
(Fig. 4a) and first performed immunoprecipitation (IP) exper-
iments in HEK cells expressing FLAG-tagged SAP102 and
E2218R Nbea to confirm loss of binding (Fig. 4b). Phospho-
fructo-kinase (PFKM), a glycolytic enzyme identified in Nbea
IPs from mouse brain fractions [15] showed direct binding
with WT Nbea when co-expressed in HEK cells (Fig. 4c).
This interaction was preserved when IPs were performed with
E2218RNbea. Hence, the E2218Rmutation does not result in
protein misfolding but specifically loses binding affinity for
SAP102. Additionally, we also discovered that WT Nbea and
E2218R Nbea bind directly with PSD95 in HEK cells (Sup
Fig. 3).
Morphological analysis of Nbea KO neurons expressing
WT Nbea or E2218R Nbea showed similar distribution of
Nbea in both conditions (Fig. 4d, e, h). Like in the SAP102
null mutant neurons, dendritic length of Nbea KO neurons
expressing E2218RNbea was significantly reduced compared
to neurons expressing WT Nbea (Fig. 4f). The intensity of
Nbea puncta was reduced in cells expressing E2218R Nbea
(Fig. 4g). However, the distribution of WT Nbea and E2218R
Nbea puncta was unaltered (Fig. 4h).
To investigate the effect of SAP102 interaction on
synaptic transmission, we rescued Nbea KO neurons
with WT Nbea or E2218R Nbea. Exogenous application
of 30-μM glutamate on WT Nbea-expressing neurons
showed a complete rescue of synaptic transmission as
demonstrated previously [11]. In contrast, glutamate-
induced responses in E2218R Nbea expressing neurons
were strongly reduced (Fig. 5a, b), whereas 3-μM
GABA-induced responses in E2218R Nbea neurons
were comparable to null mutants expressing WT Nbea
(Fig. 5c). E2218R Nbea neurons showed reduced spon-
taneous frequency (Fig. 5e) and amplitude (Fig. 5f)
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compared to WT Nbea rescued neurons. Together, these
data suggest that the Nbea-SAP102 interaction is vital
for glutamate receptor signalling but not required to
support GABA receptor signalling.
Discussion
In Nbea null neurons, AMPA, GABA and NMDA receptors
are not targeted and expressed at the synapse surface. Several
experiments have demonstrated that this loss of receptor ex-
pression is restricted to synapse while extra-synaptic receptor
expression is unaffected [11]. Here, we show deletion of
hypothesised PKA II binding site in Nbea results in decrease
of GABA receptor surface expression (Fig. 1l–n) and the
E2218R mutation in Nbea produced a selective loss of
glutamate-induced synaptic responses (Fig. 5a–c). SAP102
KO mice have reduced expression of Nbea (Fig. 2a–g) but
unaffected glutamate induced synaptic responses (Fig. 3c–d).
Conversely, synaptic transmission was impaired in Nbea null
mutant neurons even though SAP102 levels were normal
(Fig. 2h–m, [11].
Nbea, as an AKAP, Modulates Receptor Targeting
to Synapse
Nbea is an AKAP belonging to a family of BEACH domain
proteins. Some of these proteins, such as Lyst or Bchs regulate
lysosome-related organelles whereas AKAP550 anchors other
proteins [24]. AKAP proteins are of central importance in
cellular function due to their ability to interact directly with
protein kinases via a common motif at their C-terminus that
Fig. 4 E2218R Nbea does not bind to SAP102 in heterologous cells. a
Schematic drawing of mouse Nbea and the PH domain in which the
E2218R mutation was generated. b Immunoblot of a HEK cell IP
shows that SAP102 interacts with WT Nbea but does not bind with
E2218R Nbea. c Immunoblot of a HEK293T cell IP shows that
phospho-fructo-kinase (PFKM), another interactor of Nbea, binds with
both WT Nbea and E2218R Nbea. d Representative image of Nbea KO
expressed with WT Nbea and E2218R Nbea depicts similar distribution
in cultured neurons. e Total number of Nbea puncta in a neuron is not
different between WT Nbea and E2218R Nbea. f Dendritic length of
Nbea KO neurons rescued with E2218R Nbea is shorter than WT Nbea
(Nbea KO + WT Nbea: n=49, 5.1±0.3 mm, Nbea KO + E2218R Nbea:
n=47, 3.6±0.2 mm, Mann-Whitney test, U=610, ***p<0.001). g Scholl
analysis shows that E2218R Nbea distribution in dendrite is same as WT
Nbea. h E2218R Nbea intensity in dendrites is greatly reduced compared
to WT Nbea (Nbea KO + WT Nbea: 633.4±24.13, n=49, Nbea KO +
E2218R Nbea: 300.3±13.82 mm, n=47, Mann-Whitney test, ***
p<0.001). All data are mean±SEM
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Fig 5 E2218R Nbea does not target Glutamate receptors to the synaptic
surface as well as WT Nbea upon expression in Nbea null neurons. a
Representative trace of exogenously applied glutamate and GABA puff
on Nbea KO neurons; Nbea KO rescued with WT Nbea and Nbea KO
rescued with E2218R Nbea. b E2218R Nbea does not rescue glutamate-
induced response as well as WT Nbea in Nbea KO neurons (Nbea KO=
303.56±38.95pA, n=40, Nbea KO +WTNbea=917.4±86.15pA, n=30,
Nbea KO + E2218R Nbea=462.3±59.14, n=34, 6 independent
experiments). A two-level multilevel statistical analysis was performed
including random intercepts. c E2218R Nbea rescues GABA induced
response as well as WT Nbea in Nbea KO neurons (Nbea KO=475±
84.65pA, n=44, Nbea KO + WT Nbea=1001.32±162.50pA, n=44,
Nbea KO + E2218R Nbea=908.36±151.55pA, n=43, 4 independent
experiments). A two-level multilevel statistical analysis was performed
with intercept and slope modelled as random coefficients. d
Representative trace of spontaneous minis of Nbea KO neurons; Nbea
KO rescued with WT Nbea, Nbea KO rescued with E2218R Nbea. e
Amplitude of spontaneous minis of Nbea KO neurons rescued with
E2218R is significantly decreased compared to WT Nbea rescue but
non-significant compared to Nbea KO neurons (Nbea KO=23.31±
1.20pA, n=42, Nbea KO + WT Nbea=25.97±1.48 pA, n=39, Nbea
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experiments). A two-level multilevel statistical analysis was performed
including random intercepts. f Frequency of spontaneous minis of Nbea
KO neurons rescued with E2218R is significantly decreased compared to
WTNbea rescue, whereas non-significant compared to Nbea KO neurons
(Nbea KO=4.04±0.86, n=42, Nbea KO +WTNbea=4.92±0.64, n=39,
Nbea KO + E2218R Nbea= 3.29 ± 0.47, n=4, 7 independent
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including random intercepts (***p<0.001, **p<0.01, *p<0.05). All data
are mean±SEM
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binds to regulatory subunits of protein kinases and concen-
trates their intracellular location and regulates their activity
[25]. Due to their importance in local signalling events,
AKAPs are targets for therapeutic intervention [26]. Nbea
interaction with PKA II was found through plasma resonance
imaging [16] with a hypothesised 17 amino acid binding site.
Deletion of this domain in full length Nbea prevented full
rescue of GABA receptor expression on the synapse surface
(Fig. 1h, j). This suggests that anchoring and/or concentrating
PKA II is important for the insertion of GABA receptors (al-
though a trend towards incomplete rescue of glutamate-
induced responses was also observed, Fig. 1m). Protein kinase
A is known to regulate inhibitory receptors such as glycine
receptor-induced Cl− currents by increasing the probability of
channel openings [27]. Reduction of mPSC amplitude and
mPSC frequency in Nbea KO can be rescued with re-
introduction of WT Nbea [11]. We do not see any difference
in the mPSC amplitude and frequency of neurons rescued with
NbeaΔPKA compared to the other two groups. Our data show
that Nbea essentially does not require PKA binding to perform
its function but this interaction modulates inhibitory and ex-
citatory receptor surface expression.
E2218R Nbea Mutant Suggests That SAP102 Binding
to Nbea Is Essential for Excitatory but not Inhibitory
Transmission
Expression of the E2218R Nbea mutant in Nbea KO neurons
did not restore glutamate receptor expression at the synapse
surface (Fig. 5a, b). Additionally, significantly reduced mPSC
amplitude and frequency in neurons rescued with E2218R
Nbea compared to WT Nbea rescue suggests reduced expres-
sion of synaptic receptors (Fig. 5d–f). As AKAP-MAGUK-
NMDA receptor complexes are known to exist [28], we pre-
dicted that Nbea indirectly interacts with NMDA receptors via
SAP102 to target receptors to the synapse surface. This mech-
anism might be similar to the SAP97/Dlg1 interaction with
AKAP97, which is disrupted by calmodulin-dependent pro-
tein kinase II resulting in a decrease of GluR1-mediated
AMPA receptor currents [29]. Nbea KO neurons expressed
with E2218R Nbea have shorter dendritic length than neurons
with WT Nbea (Fig. 4f), which is a phenocopy of shorter
dendrites present in SAP102 KO neurons (Fig. 2d). We did
not observe changes in glutamate-induced responses in
SAP102 KO neurons (Fig. 3c, d). PSD95 interaction with
WTNbea and E2218RNbea (Suppl Fig. 3) suggests that other
MAGUK/Dlgs maybe taking over the function of SAP102 in
SAP102 null mice, potentially via the promiscuous PDZ-
binding ligand found in all NR2 subunits of the NMDA re-
ceptors [30,31]. Overlapping functions of PSD95, PSD93 and
SAP102 in transport of glutamate receptor trafficking has
been documented, in which only knocking out two or three
MAGUKs results in severe loss of receptor signalling [32].
Additionally, both PSD95 and SAP102 knockout mice show
enhanced hippocampal long-term potentiation consistent with
a similar signalling function [33]. Developmental switches
and redundant functions among different MAGUKs [4,34]
might explain the fact that the synaptic machinery is intact
in SAP102 KO mice. In line with this idea, acute SAP102
knock down in neurons produced unique phenotypes, not ob-
served upon chronic deletion of SAP102 expression in null
mutant mice [35]. These phenotypes, for instance a reduced
excitatory synaptogenesis [35] point in the same direction as
morphological and functional changes observed when the in-
teraction between SAP102 and Nbea is prevented (using the
E2218R mutant).
Cellular Nbea Stability Depends on SAP102
Analysis ofNbea null brain homogenate and cultured neurons
showed no difference in cellular levels in many pre- and post
synaptic proteins [11], while synapsin, synaptophysin and
Mint1 were found to differentially expressed in the brain stem
of Nbea null mice [14]. Our observation that SAP102 protein
levels are unchanged in Nbea null mice demonstrates that loss
of Nbea does not have a general effect on stability or trans-
portation of other proteins in cultured neurons. However,
Nbea protein levels are greatly reduced in SAP102 null neu-
rons and brain homogenate (Fig. 2a–g). The Nbea mutant that
abolished SAP102 binding showed a lower staining intensity
when expressed in null mutant neurons than the wild type
Nbea protein (Fig. 4h). Nbea mRNA levels are unchanged
in SAP102 null neurons (Suppl Fig. 2a). This suggests that
SAP102 regulates stability of Nbea protein and we show that
in the absence of SAP102, Nbea protein is degraded via the
ubiquitin-proteasome pathway (Suppl Fig. 2b, c). The 80 %
reduction in Nbea protein levels at E18 still results in normal
synaptic transmission in SAP102 KO mice (Fig. 3c, d).
Functional Changes in Nbea Null Synapses Might Have
Structural Consequences
We observe changes in synaptic surface expression of recep-
tors in Nbea null neurons. Functional changes can lead to
structural changes in neuronal network. Cultured Nbea null
neurons from the brain stem have an impaired development
and function of spinous synapses with an accumulation of F-
actin and synaptopodin [13]. Shorter spine density is possibly
due to decrease in surface expression of post-synaptic recep-
tors on the synapse surface that we observe due to Nbea loss.
Nbea Targets Excitatory and Inhibitory Post-Synaptic
Receptors via Distinct Pathways
Nbea immunoreactivity was found to be apposed to certain
inhibitory synapses [36] juxtaposed to the Golgi complex and
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accumulated in endosome-like organelles in dendrites [11].
Hence, Nbea resides probably at locations in the cell where
receptors and their interacting proteins assemble for targeting
to the synaptic membrane. The interaction between Nbea,
PKAII and SAP102 might also take place at such locations,
upstream of insertion of receptors at the synapse surface. To
our knowledge, Nbea is the first protein that regulates synaptic
receptor expression to both excitatory and inhibitory synapses.
The current data now demonstrate that Nbea orchestrates these
trafficking routes using distinct pathways, one resistant to the
loss of SAP102-NBea interaction (GABA-receptor targeting)
and one that is not supported by the Nbea mutant that abol-
ishes this interaction (glutamate receptor targeting).
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